Skip to main content
Top
Published in: AIDS and Behavior 1/2015

01-01-2015 | Original Paper

Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients: Findings of the CAPRISA 058 Randomised Controlled Trial

Authors: Francois van Loggerenberg, Alison D. Grant, Kogieleum Naidoo, Marita Murrman, Santhanalakshmi Gengiah, Tanuja N. Gengiah, Katherine Fielding, Salim S. Abdool Karim

Published in: AIDS and Behavior | Issue 1/2015

Login to get access

Abstract

Concerns that standard didactic adherence counselling may be inadequate to maximise antiretroviral therapy (ART) adherence led us to evaluate more intensive individualised motivational adherence counselling. We randomised 297 HIV-positive ART-naïve patients in Durban, South Africa, to receive either didactic counselling, prior to ART initiation (n = 150), or an intensive motivational adherence intervention after initiating ART (n = 147). Study arms were similar for age (mean 35.8 years), sex (43.1 % male), CD4+ cell count (median 121.5 cells/μl) and viral load (median 119,000 copies/ml). Virologic suppression at 9 months was achieved in 89.8 % of didactic and 87.9 % of motivational counselling participants (risk ratio [RR] 0.98, 95 % confidence interval [CI] 0.90–1.07, p = 0.62). 82.9 % of didactic and 79.5 % of motivational counselling participants achieved >95 % adherence by pill count at 6 months (RR 0.96, 95 % CI 0.85–1.09, p = 0.51). Participants receiving intensive motivational counselling did not achieve higher treatment adherence or virological suppression than those receiving routinely provided didactic adherence counselling. These data are reassuring that less resource intensive didactic counselling was adequate for excellent treatment outcomes in this setting.
Footnotes
1
We refer to patients in the treatment programme, and to participants when enrolled onto this study.
 
Literature
1.
go back to reference UNAIDS. AIDS epidemic update : november 2009. Geneva: WHO; 2009. UNAIDS. AIDS epidemic update : november 2009. Geneva: WHO; 2009.
2.
go back to reference Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84.PubMedCrossRef Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84.PubMedCrossRef
4.
go back to reference Jones R, Gazzard B. The cost of antiretroviral drugs and influence on prescribing policies. Int J STD AIDS. 2006;17(8):499–506.PubMedCrossRef Jones R, Gazzard B. The cost of antiretroviral drugs and influence on prescribing policies. Int J STD AIDS. 2006;17(8):499–506.PubMedCrossRef
5.
go back to reference Orrell C. Antiretroviral adherence in a resource-poor setting. Curr HIV/AIDS Rep. 2005;2(4):171–6.PubMedCrossRef Orrell C. Antiretroviral adherence in a resource-poor setting. Curr HIV/AIDS Rep. 2005;2(4):171–6.PubMedCrossRef
6.
go back to reference Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef
7.
go back to reference Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(1):S23–35.PubMedCentralPubMedCrossRef Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(1):S23–35.PubMedCentralPubMedCrossRef
8.
go back to reference Abdool Karim SS, Abdool Karim Q, Friedland G, Lalloo U, El-Sadr WM. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS. 2004;18(7):975–9.PubMedCrossRef Abdool Karim SS, Abdool Karim Q, Friedland G, Lalloo U, El-Sadr WM. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS. 2004;18(7):975–9.PubMedCrossRef
9.
go back to reference Shisana O, Simbayi L, editors. Nelson Mandela/HSRC Study of HIV/AIDS. South African national HIV prevalence, behavioural risks and mass media. Household survey 2002. Cape Town: Human Sciences Research Council; 2002. Shisana O, Simbayi L, editors. Nelson Mandela/HSRC Study of HIV/AIDS. South African national HIV prevalence, behavioural risks and mass media. Household survey 2002. Cape Town: Human Sciences Research Council; 2002.
10.
go back to reference Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(3):S123–7.PubMedCrossRef Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(3):S123–7.PubMedCrossRef
11.
go back to reference Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed
12.
go back to reference Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef
13.
go back to reference Gordon CM. Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions: research directions and implications for practice. J Acquir Immune Defic Syndr. 2006;43(1):S36–40.PubMedCrossRef Gordon CM. Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions: research directions and implications for practice. J Acquir Immune Defic Syndr. 2006;43(1):S36–40.PubMedCrossRef
14.
go back to reference Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, Schmetter B, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(1):S41–7.PubMedCrossRef Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, Schmetter B, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(1):S41–7.PubMedCrossRef
15.
go back to reference Cote JK, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS. 2005;16(5):335–43.PubMedCrossRef Cote JK, Godin G. Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS. 2005;16(5):335–43.PubMedCrossRef
16.
go back to reference Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21.PubMedCentralPubMedCrossRef Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21.PubMedCentralPubMedCrossRef
17.
go back to reference DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCentralPubMedCrossRef DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCentralPubMedCrossRef
18.
go back to reference Davies G, Koenig LJ, Stratford D, Palmore M, Bush T, Golde M, et al. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART. AIDS Care. 2006;18(8):895–903.PubMedCrossRef Davies G, Koenig LJ, Stratford D, Palmore M, Bush T, Golde M, et al. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART. AIDS Care. 2006;18(8):895–903.PubMedCrossRef
19.
go back to reference Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159–69.PubMedCrossRef Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159–69.PubMedCrossRef
20.
go back to reference Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697–706.PubMedCentralPubMedCrossRef Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697–706.PubMedCentralPubMedCrossRef
21.
go back to reference Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J med. 2011;365(16):1492–501.PubMedCentralPubMedCrossRef Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J med. 2011;365(16):1492–501.PubMedCentralPubMedCrossRef
22.
go back to reference Department of Health. National antiretroviral treatment guideliness. Pretoria: National Department of Health; 2004. Department of Health. National antiretroviral treatment guideliness. Pretoria: National Department of Health; 2004.
23.
go back to reference WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach (2003 revision). Geneva: World Health Organization; 2004. WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach (2003 revision). Geneva: World Health Organization; 2004.
24.
go back to reference DHHS. Guidelines for the use of antiretroviral agents in hiv-1-infected adults and adolescents. Washington: DHHS; 2004. DHHS. Guidelines for the use of antiretroviral agents in hiv-1-infected adults and adolescents. Washington: DHHS; 2004.
25.
go back to reference Fisher J, Fisher W, Bryan A, Misovich S. Information-motivation-behavioural skills model-based HIV risk behaviour change interventions for inner city high school youth. Health Psychol. 2002;21(2):177–86.PubMedCrossRef Fisher J, Fisher W, Bryan A, Misovich S. Information-motivation-behavioural skills model-based HIV risk behaviour change interventions for inner city high school youth. Health Psychol. 2002;21(2):177–86.PubMedCrossRef
26.
go back to reference Fisher JD, Fisher WA. The information-motivation-behavioural skills model. In: DiClemente RJ, Crosby RA, Kegler MC, editors. Emerging theories in health promotion practice and research. San Francisco: Jossey-Bass; 2002. p. 40–70. Fisher JD, Fisher WA. The information-motivation-behavioural skills model. In: DiClemente RJ, Crosby RA, Kegler MC, editors. Emerging theories in health promotion practice and research. San Francisco: Jossey-Bass; 2002. p. 40–70.
27.
go back to reference Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.PubMedCrossRef Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.PubMedCrossRef
28.
go back to reference Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41(1):44–52.PubMedCrossRef Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41(1):44–52.PubMedCrossRef
29.
30.
go back to reference Emmons KM, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med. 2001;20(1):68–74.PubMedCrossRef Emmons KM, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med. 2001;20(1):68–74.PubMedCrossRef
31.
go back to reference Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305–12.PubMedCentralPubMed Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305–12.PubMedCentralPubMed
32.
go back to reference Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908.PubMedCrossRef Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908.PubMedCrossRef
33.
go back to reference Lawn SD, Little F, Bekker LG, Kaplan R, Campbel E, Orrell C, et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS. 2009;23(3):335–42.PubMedCentralPubMedCrossRef Lawn SD, Little F, Bekker LG, Kaplan R, Campbel E, Orrell C, et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS. 2009;23(3):335–42.PubMedCentralPubMedCrossRef
34.
go back to reference Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef
35.
go back to reference Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.PubMedCrossRef
36.
go back to reference Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, Geelen SP, et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis. 2008;27(10):977–84.PubMedCrossRef Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, Geelen SP, et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis. 2008;27(10):977–84.PubMedCrossRef
37.
go back to reference Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.PubMedCentralPubMedCrossRef Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.PubMedCentralPubMedCrossRef
38.
go back to reference Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS, Newell ML. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593–600.PubMedCentralPubMedCrossRef Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS, Newell ML. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593–600.PubMedCentralPubMedCrossRef
39.
go back to reference McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.PubMedCentralPubMedCrossRef McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.PubMedCentralPubMedCrossRef
40.
go back to reference Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44–51.PubMedCentralPubMedCrossRef Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44–51.PubMedCentralPubMedCrossRef
Metadata
Title
Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients: Findings of the CAPRISA 058 Randomised Controlled Trial
Authors
Francois van Loggerenberg
Alison D. Grant
Kogieleum Naidoo
Marita Murrman
Santhanalakshmi Gengiah
Tanuja N. Gengiah
Katherine Fielding
Salim S. Abdool Karim
Publication date
01-01-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0763-6

Other articles of this Issue 1/2015

AIDS and Behavior 1/2015 Go to the issue